SCHEMBL4833351

SCHEMBL4833351

CCCc1ccc(S(=O)(=O)Nc2ccc(N3C=Nc4occc4C3N)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR4 Q5NUL3 2/20 0.40
▸ FFAR1 O14842 1/20 0.40
▸ KIT P10721 1/20 0.40
▸ MAPT P10636 1/20 0.39
▸ ATM Q13315 1/20 0.39
▸ HSP90AA1 P07900 1/20 0.39
▸ HSP90AB1 P08238 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ NAMPT P43490 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.38
▸ NR1I2 O75469 1/20 0.38
▸ UCHL1 P09936 1/20 0.37
▸ JAK2 O60674 1/20 0.37
▸ DRD2 P14416 2/20 0.36
▸ DRD3 P35462 2/20 0.36
▸ KCNH2 Q12809 1/20 0.36
▸ KEAP1 Q14145 1/20 0.36
▸ NFE2L2 Q16236 1/20 0.36
▸ HTR6 P50406 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4833717 0.94 FFAR1 (0.48) FFAR4FFAR1KITMAPTATM
SCHEMBL4830928 0.92 UCHL1 (0.46) FFAR4KITMAPTLMNATP53
SCHEMBL4834296 0.86 SMN1; SMN2 (0.47) MAPTLMNATP53ALDH1A1KMT2A
SCHEMBL4834410 0.85 CA1 (0.47) FFAR4FFAR1MAPTLMNAALDH1A1
SCHEMBL4833953 0.85 PKM (0.44) MAPTLMNAALDH1A1NR1I2KEAP1
SCHEMBL4833811 0.85 POLB (0.47) KITMAPTLMNAALDH1A1DRD2
SCHEMBL4834025 0.85 CA1 (0.50) FFAR4FFAR1MAPTLMNANAMPT
SCHEMBL4831477 0.85 ALDH1A1 (0.48) MAPTLMNAALDH1A1KEAP1NFE2L2
SCHEMBL4833624 0.84 POLB (0.49) MAPTLMNATP53ALDH1A1KMT2A
SCHEMBL4831006 0.83 NPY5R (0.42) KITMAPTLMNADRD3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080287466-A1 4-AMINO-2,3-DISUBSTITUTED THIENO [2,3,D]PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS THEREOF ADAMS JERRY LEROY 2008-11-20 — — US claimed
US-20050004142-A1 Chemical compounds SMITHKLINE BEECHAM CORPORATION 2005-01-06 — — US claimed
US-20080287466-A1 4-AMINO-2,3-DISUBSTITUTED THIENO [2,3,D]PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS THEREOF ADAMS JERRY LEROY 2008-11-20 — — US disclosed
US-7427623-B2 4-Amino-2,3-disubstituted thieno[2,3-d]pyrimidines and pharmacetical compositions thereof SMITHKLINE BEECHAM CORPORATION (US) 2008-09-23 — — US disclosed
US-20050004142-A1 Chemical compounds SMITHKLINE BEECHAM CORPORATION 2005-01-06 — — US disclosed
EP-1425284-A2 FURO- AND THIENOPYRIMIDINE DERIVATIVES AS ANGIOGENESIS INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2004-06-09 — — EP disclosed
WO-2003022852-A2 FURO-AND THIENOPYRIMIDINE DERIVATIVES AS ANGIOGENESIS INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2003-03-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004142-A1 Chemical compounds TIE1, KDR, TEK FFAR4 3172/4885FFAR1 3373/4885KIT 42/4885
US-20080287466-A1 4-AMINO-2,3-DISUBSTITUTED THIENO [2,3,D]PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS THEREOF TIE1, TEK, KDR FFAR4 1645/4885FFAR1 2495/4885KIT 74/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback